The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
{5-[3-(5-Carboxymethyl-thiophen-2-yl)-benzo[g]quinoxalin-2-yl]-thiophen-2-yl}-acetic acid ID: ALA193162
PubChem CID: 10183039
Max Phase: Preclinical
Molecular Formula: C24H16N2O4S2
Molecular Weight: 460.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)Cc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CC(=O)O)s2)s1
Standard InChI: InChI=1S/C24H16N2O4S2/c27-21(28)11-15-5-7-19(31-15)23-24(20-8-6-16(32-20)12-22(29)30)26-18-10-14-4-2-1-3-13(14)9-17(18)25-23/h1-10H,11-12H2,(H,27,28)(H,29,30)
Standard InChI Key: JKZIETFCILCHEP-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
2.3417 -1.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3292 -1.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6250 -2.3167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6167 -0.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0417 -0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0542 -2.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8000 -0.9792 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 -3.1292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -1.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9042 -1.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3417 -0.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9542 -3.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 0.1708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8042 -1.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1667 -0.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3000 -4.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -2.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9292 0.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1917 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1875 -0.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6417 0.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1167 -4.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5208 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5208 -1.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3042 0.9833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6000 -3.4542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4625 -4.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4667 0.1583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2375 -2.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2375 -0.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9500 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9500 -1.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 2 2 0
5 2 1 0
6 1 1 0
7 5 1 0
8 6 1 0
9 10 1 0
10 3 1 0
11 7 1 0
12 8 1 0
13 5 2 0
14 6 2 0
15 11 1 0
16 12 1 0
17 14 1 0
18 13 1 0
19 10 2 0
20 9 2 0
21 15 1 0
22 16 1 0
23 24 1 0
24 19 1 0
25 21 2 0
26 22 2 0
27 22 1 0
28 21 1 0
29 24 2 0
30 23 2 0
31 32 2 0
32 29 1 0
12 17 2 0
4 9 1 0
11 18 2 0
23 20 1 0
30 31 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 460.54Molecular Weight (Monoisotopic): 460.0551AlogP: 5.49#Rotatable Bonds: 6Polar Surface Area: 100.38Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.31CX Basic pKa: ┄CX LogP: 5.45CX LogD: 0.04Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.32Np Likeness Score: -0.48
References 1. Székelyhidi Z, Pató J, Wáczek F, Bánhegyi P, Hegymegi-Barakonyi B, Erös D, Mészáros G, Hollósy F, Hafenbradl D, Obert S, Klebl B, Kéri G, Orfi L.. (2005) Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives., 15 (13): [PMID:15925511 ] [10.1016/j.bmcl.2005.04.064 ]